4//SEC Filing
Iwanicki David 4
Accession 0001140361-07-012727
CIK 0000882104other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 7:49 PM ET
Size
24.5 KB
Accession
0001140361-07-012727
Insider Transaction Report
Form 4
Iwanicki David
VP, Sales & Sales Operations
Transactions
- Exercise/Conversion
Common Stock
2007-06-20$17.13/sh+645$11,049→ 645 total - Sale
Common Stock
2007-06-20$24.35/sh−60$1,461→ 585 total - Sale
Common Stock
2007-06-20$24.30/sh−65$1,580→ 520 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2007-06-20−645→ 23,905 totalExercise: $17.13Exp: 2013-07-20→ Common Stock (645 underlying)
Footnotes (2)
- [F1]Sale was made pursuant to a 10b5-1 plan established by the reporting person.
- [F2]Option vests with respect to approximately 645 shares per month and 9 shares remained exercisable immediately after this transaction. Only vested options are exercisable
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001322481
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 7:49 PM ET
- Size
- 24.5 KB